1:Josep Carreras Leukaemia Research Institute

Here, I will provide an introduction to the field of adoptive T-cell redirecting strategies in hematological and solid tumors. We will focus on how CAR-based immunotherapies have revolutionized cancer treatment and will discuss also the large window of opportunity existing to improve further such therapies in leukemias and solid tumors.